2610044O15Rik Inhibitors
Chemical inhibitors of the protein 2610044O15Rik can interact with various signaling pathways to inhibit its function. SB203580, a selective inhibitor of p38 MAP kinase, can disrupt the kinase's activity, which may be crucial for the role of 2610044O15Rik in cytokine production and cell differentiation. Similarly, the PI3K inhibitors LY294002 and Wortmannin can hinder the PI3K/AKT signaling pathway, possibly affecting the functional role of 2610044O15Rik if it is involved in this pathway. Inhibition of PI3K can prevent the activation of downstream components that are essential for the activity of numerous proteins, including 2610044O15Rik. Rapamycin, which targets mTOR, a key regulator of cell growth and proliferation, can also inhibit the function of 2610044O15Rik if there is a connection between mTOR signaling pathways and the protein's activity.
Another chemical, PD98059, selectively inhibits MEK, which is upstream of ERK in the MAPK pathway, potentially leading to the inhibition of 2610044O15Rik if it relies on this signaling cascade. SP600125, which inhibits JNK, and U0126, a MEK1/2 inhibitor, can also suppress the MAPK/ERK pathway, impacting the functional role of 2610044O15Rik. ZM-447439, an Aurora kinase inhibitor, disrupts cell division processes and can inhibit 2610044O15Rik if the protein's activity is linked to Aurora kinase-regulated cell cycle events. PP2, an inhibitor of Src family tyrosine kinases, can influence the function of 2610044O15Rik by inhibiting Src kinase activity, affecting signaling pathways involving Src kinases. Bortezomib, a proteasome inhibitor, can affect the degradation process of intracellular proteins, potentially inhibiting the function of 2610044O15Rik if it is involved in proteasomal pathways. Thapsigargin, which inhibits SERCA, can alter calcium homeostasis and affect 2610044O15Rik by interfering with calcium-dependent signaling pathways. Finally, Staurosporine, a broad-spectrum protein kinase inhibitor, can inhibit the activity of 2610044O15Rik through its action on various protein kinases essential for phosphorylation processes that 2610044O15Rik may depend on.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. Inhibition of p38 MAP kinase can disrupt cellular processes such as cytokine production and cell differentiation, which, if 2610044O15Rik is involved in these processes, would lead to the functional inhibition of 2610044O15Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K. By inhibiting PI3K, LY294002 may hinder downstream AKT signaling, potentially leading to the functional inhibition of 2610044O15Rik if it is involved in PI3K/AKT pathway-dependent processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can disrupt PI3K-dependent signaling pathways. The inhibition of PI3K can functionally inhibit 2610044O15Rik by preventing activation of downstream components that may be essential for its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation. By inhibiting mTOR, Rapamycin can functionally inhibit 2610044O15Rik if the protein is involved in mTOR signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which is upstream of ERK in the MAPK pathway. Inhibition of MEK and subsequently ERK can lead to the functional inhibition of 2610044O15Rik if it operates within this signaling cascade. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the MAP kinase pathway. Inhibition of JNK signaling can lead to the functional inhibition of 2610044O15Rik if it relies on JNK for its activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor, which can prevent the activation of the MAPK/ERK pathway. This inhibition can functionally inhibit 2610044O15Rik if it is dependent on this pathway for its activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor, disrupting processes like cell division. This can functionally inhibit 2610044O15Rik if the protein's activity is linked to cell cycle regulation by Aurora kinases. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Inhibition of Src kinase activity can lead to the functional inhibition of 2610044O15Rik if it is involved in Src signaling pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can lead to the accumulation of proteins and cell cycle arrest, functionally inhibiting 2610044O15Rik if it is involved in proteasome-dependent regulatory processes. | ||||||